Anna has over 12 years’ experience across industry and academic clinical trials. Originally from Ireland, she lived and worked in Australia from 2009 to 2023 before returning home.
Anna is the EU Representative in the governance team for the Global Angelman Syndrome Registry. She is an integral part of the Registry’s governance, providing oversight and expertise to ensure compliance with GDPR and EU data protection requirements, reflecting the Registry’s significant engagement with European data.